Publications by authors named "Thomas Cottin"

Claim this Profile
A
A sulindac analogue is effective against malignant pleural effusion in mice.
Charalampos Moschos, Ioannis Psallidas, Thomas Cottin, Androniki Kollintza, Spyros Papiris

Lung Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 5,6-spiroethers and evaluation of their affinities for the bacterial A site.
Ioannis A Katsoulis, Georgia Kythreoti, Athanasios Papakyriakou, Konstantina Koltsida, Panoula Anastasopoulou, Thomas Cottin

Chembiochem· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designed spiro-bicyclic analogues targeting the ribosomal decoding center.
Thomas Cottin, Constantina Pyrkotis, Christos I Stathakis, Ioannis Mavridis, Ioannis A Katsoulis

Chembiochem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second generation analogs of rigid 6,7-spiro scaffolds targeting the bacterial ribosome.
Christos I Stathakis, Ioannis Mavridis, Georgia Kythreoti, Athanasios Papakyriakou, Ioannis A Katsoulis, Thomas Cottin

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonin derivatives as a new class of non-ATP-competitive receptor tyrosine kinase inhibitors.
Anita Büttner, Thomas Cottin, Jing Xu, Lito Tzagkaroulaki, Athanassios Giannis

Bioorg Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of SANT-2 and analogues as inhibitors of the hedgehog signaling pathway.
Anita Büttner, Katrin Seifert, Thomas Cottin, Vasiliki Sarli, Lito Tzagkaroulaki

Bioorg Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and biological evaluation of a novel aurora A kinase inhibitor.
Teresa Sardon, Thomas Cottin, Jing Xu, Athanassios Giannis, Isabelle Vernos

Chembiochem· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indeno[1,2-d]pyrido[1,2-a]pyrimidines: a new class of receptor tyrosine kinase inhibitors.
Maria Tsanakopoulou, Thomas Cottin, Anita Büttner, Vasiliki Sarli, Elizabeth Malamidou-Xenikaki

ChemMedChem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis